Comparison of 15 different stents in superficial femoral arteries by high resolution MRI ex vivo and in vivo

Journal of Magnetic Resonance Imaging

Volumn 22, Issue 1, 2005, Pages 125-135

  Adams, Gareth J ^a   Baltazar, Ulises ^a   Karmonik, Christof ^a   Bordelon, Cassius ^a   Lin, Peter H ^a   Bush, Ruth L ^a   Lumsden, Alan B ^a   Morrisett, Joel D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Magnetic resonance imaging; MRI; SFA; Stent; Superficial femoral artery

Indexed keywords

NITINOL;

ARTICLE; BLOOD VESSEL WALL; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIGNAL NOISE RATIO; STENT; SUPERFICIAL FEMORAL ARTERY;

ALLOYS; ARTIFACTS; CADAVER; FEMORAL ARTERY; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; RECURRENCE; STAINLESS STEEL; STENTS;

EID: 21244431988     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20359     Document Type: Article

References (26)

1. Fowkes GR, Housley E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral artery disease in the general population. Int J Epidemiol 1991;20:384-391.
2. Bainton D, Sweetnam P, Baker I, et al., Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J 1994;72: 128-132.
3. de Graaff JC, Ubbink DT, Kools EI, et al. The impact of peripheral and coronary artery disease on health-related quality of life. Ann Vasc Surg 2002;16:495-500.
4. Burns P, Lima E, Bradbury AW. What constitutes best medical therapy for peripheral arterial disease? Eur J Vasc Endovasc Surg 2002;24:6-12.
5. Zhang S, Hatsukami TS, Polissar NL, et al. Comparison of carotid vessel wall area measurements using three different contrast-weighted black blood MR imaging techniques. Magn Reson Imaging 2001;19:795-802.
6. Yuan C, Lin E, Millard J, et al. Closed contour edge detection of blood vessel lumen and outer wall boundaries in black-blood MR images. Magn Reson Imaging 1999;17:257-266.
7. Yuan C, Beach KW, Smith LH, et al. Measurement of atherosclerotic carotid plaque size in vivo using high resolution magnetic resonance imaging. Circulation 1998;98:2666-2671.
8. Zhao XQ, Yuan C, Hatsukami TS, et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol 2001;21:1623-1629.
9. Corti R, Fayad ZA, Fuster V, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001;104:249-252.
10. Corti R, Fayad ZA, Fuster V, et al. Lipid lowering by Simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002;106:2884-2887.
11. Gordon IL, Conroy RM, Arepi M, et al. Three-year outcome of endovascular treatment of superficial femoral artery occlusion. Arch Surg 2001;136:221-228.
12. Lugmayr HF, Holzer H, Kastner M, et al. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a midterm follow-up. Radiology 2002;222: 37-43.
13. Holton A, Walsh E, Anayiotos A, et al. Comparative MRI compatibility of 316 L stainless steel alloy and nickel-titanium alloy stents. J Cardiovasc Magn Reson 2002;4:423-430.
14. Maintz D, Botnar RM, Fischbach R, et al. Coronary magnetic resonance angiography for assessment of the stent lumen: a phantom study. J Cardiovasc Magn Reson 2002;4:359-367.
15. Klemm T, Duda S, Machann J, et al. MR imaging in the presence of vascular stents: a systematic assessment of artifacts for various stent orientations, sequence types, and field strengths. J Magn Reson Imaging 2000;12:606-615.
16. Bartels LW, Smits HF, Bakker CJ, et al. MR imaging of vascular stents: effects of susceptibility, flow, and radiofrequency eddy currents. J Vasc Interv Radiol 2001;12:365-371.
17. Botnar RM, Perez AS, Witte S, et al. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin binding molecular magnetic resonance contrast agent. Circulation 2004;109:2023-2029.
18. Shellock FG. Reference manual for magnetic resonance safety, implants, and devices. Los Angeles: Biomedical Research Publishing Group: 2004. p 317.
19. Wang Y, Truong TN, Yen C, et al. Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, and stainless steel stents. Magn Reson Med 2003;49:972-976.
20. Bartels LW, Bakker CJ, Viergever MA, et al. Improved lumen visualization in metallic vascular implants by reducing RF artifacts. Magn Reson Med 2002;47:171-180.
21. Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003;107: 381-383.
22. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002;106:1505-1509.
23. Sousa JE, Costa MA, Abizaid A, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003;107:24-27.
24. van der Laan MJ, Bartels LW, Bakker CJ, et al. Suitability of 7 aortic stent graft models for MRI based surveillance. J Endovasc Ther 2004;11:366-371.
25. Adams GJ, Greene J, Vick GW, et al. Tracking regression and progression of atherosclerosis in human carotid arteries using high resolution magnetic resonance imaging. Magn Reson Imaging 2004;22:1249-1258.
26. Morrisett JD, Vick W, Sharma R, et al. Discrimination of components in atherosclerotic plaques from human carotid endarterectomy specimens by magnetic resonance imaging ex vivo. Magn Reson Imaging 2003;21:465-474.